BioDuro, Formex to merge

Monday, November 16, 2015

BioDuro, a global CRO leader focused on preclinical chemistry, biology, and fully outsourced integrated drug development services for pharmaceutical partners, has announced the merger of its U.S. operations with Formex, a provider of pharmaceutical API formulation, development and cGMP manufacturing.

[Read More]

PPD names chief scientific officer of BioDuro

Wednesday, August 17, 2011

PPD has named Jasmine (Jisong) Cui, Ph.D., chief scientific officer of BioDuro, a PPD Company. Cui will provide scientific leadership to BioDuro’s integrated drug discovery services across a range of disease areas and expand its use of novel technologies for small and large molecules and in stem cells and imaging.

[Read More]

PPD Paying Cash for Acquisitions, Shelling Out $77M for BioDuro

Monday, December 7, 2009

Wilmington, N.C.-based PPD, a global contract research organization (CRO), is spending its cash hoard in a buying spree to “dominate” the Asia-Pacific region. The CRO doled out $77 million for its latest acquisition of BioDuro, a drug discovery outsourcing company focused on integrated drug discovery programs and services. The deal was completed last week just a couple weeks after it paid cash for another CRO in China. 

[Read More]

PPD Continues China Expansion with Deal to Acquire Drug Discovery Company BioDuro

Thursday, November 19, 2009

Less than a month after announcing its acquisition of China-based contract research organization (CRO) Excel PharmaStudies and plans to dominate the Asia-Pacific region,PPD, the Wilmington, N.C.-based global CRO has signed an agreement to acquire BioDuro LLC, a drug discovery outsourcing company. The acquisition of the 660-employee company will expand PPD’s drug development capabilities in China.  

[Read More]